PUBLISHER: Grand View Research | PRODUCT CODE: 1493211
PUBLISHER: Grand View Research | PRODUCT CODE: 1493211
The U.S. external ventricular drain market size is anticipated to reach USD 1.2 billion by 2030, exhibiting a CAGR of 8.10% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by various factors such as novel product launches, rising healthcare expenditure, and increasing regulatory approval for EVD devices in traumatic brain injury treatment.
In this market, various stakeholders, including manufacturers, healthcare providers, and regulatory bodies, collaborate to ensure that effective and safe EVD solutions are readily available for patients recovering from different types of hemorrhage. For instance, in July 2023, Integra LifeSciences shared positive updates about the successful application of the Codman Bactiseal EVD catheter set in managing hydrocephalus, a complication often seen in patients who have experienced aneurysmal Subarachnoid Hemorrhage (aSAH). The outcomes emphasized favorable clinical & economic results associated with the use of this medical solution. This collective effort aims to enhance the overall quality of care and outcomes for individuals affected by this serious medical condition.
By placing an EVD, healthcare providers can consistently monitor the pressure inside the skull and make necessary adjustments to fluid drainage. This ongoing monitoring is essential for evaluating the patient's neurological condition and ensuring timely interventions.